TBX19 Gene Curation
Gene-disease assertions not curated here (add link or write note):
Disease | Congenital isolated adrenocorticotropic hormone deficiency |
---|---|
Inheritance | Autosomal recessive |
Prevalence | unknown Source: |
Rapid or full curation? | Rapid - molecular mechanism only needed Full |
ClinGen - none. GenCC - Definitive (Ambry), Strong (Invitae). No scoring needed. | |
Clinical Validity Scoring Notes and points | n/a Source: |
Clinical Validity Points Total | n/a Source: |
Clinical Validity Classification Definitive (12pts) Strong (12pts) Moderate (7-11pts) Limited (0.1-6pts) No genetic evidence Refuted Disputed |
|
Molecular Mechanism Loss of function Gain of function Dominant negative Unknown Other | Loss of function
PMID: 15613420, 12651888 |
Penetrance Complete (100%) High (≥80%) Moderate (<80% and >20%) Low (≤20%) (list source/PMID) |
Source: |
Age of Onset Congenital Pediatric Adolescent Adulthood Late adulthood (list source/PMID) |
|
Severity |
|
Clinical Features |
Sources: |
HPO Terms |
|
Gene SOPs & Notes | LINK if SOP is a long document. Short notes if it is easy to digest. eg. Last known truncating variant |
Curation Summary | The TBX19 gene is associated with autosomal recessive congenital isolated adrenocorticotropic hormone deficiency. It is characterized by very low plasma ACTH levels and very low plasma cortisol levels. It presents with severe hypoglycemia in the neonatal period that can result in seizures. Affected individuals may also have cholestasis and/or jaundice (PMID: 15613420, 12651888). |
Case ID, Curator name, Date, Jira ticket link | AO 01.13.2025 2106076990 SM-MPQ1F D-101206607-BH-4159-P-A |